Abstract: The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

Abstract: The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

Abstract: The present invention relates to anti-VP 1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

Abstract: The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

Abstract: Disclosed are various embodiments for generating a content page with markup language corresponding to user interface widgets. A user interface widget can generate markup language to be incorporated into the content page. The markup language can be analyzed to determine whether it contains a content identifier. The content identifier can be embedded within a portion of a URL. An analysis of the content identifier can be performed to determine whether the content identifier corresponds to expired content.

Abstract: The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

Abstract: Optimization preferences are defined for optimizing execution of a distributed application. Candidate sets of application parameter values may be tested in test execution environments. Measures of performance for metrics of interest are determined based upon the execution of the distributed application using the candidate sets of application parameter values. Utility curves may be utilized to compute measures of effectiveness for metrics of interest. A multi-attribute rollup operation may utilize the computed measures of effectiveness and weights to compute a grand measure of merit (MOM) for the candidate sets of application parameter values. An optimized set of application parameter values may then be selected based upon the computed grand MOMs. The optimized set of application parameter values may be deployed to a production execution environment executing the distributed application.

Abstract: The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

Abstract: A confectionery packaging is provided comprising a first part formed from a preformed shell that is substantially rigid so that the part maintains it shape. The first part holds the product to be packaged, which in the Figures is shown as a confectionery egg. Main surfaces of the first part are shaped so as to substantially conform to the shape of the confectionery egg. Consequently an open mouth to the part is provided. The egg is accessible through the open mouth. A flange is formed about the perimeter of the open mouth. The flange extends away from the main surfaces and continuously about the perimeter of the mouth and extends a substantial distance therefrom in order to provide a surface against which a second part. The confectionery packaging forms a sealed enclosure about the egg by sealing a second part to the flange. To open the packaging, the film is separated from the first part, for instance by peeling back the film.

Abstract: Disclosed is a confectionery packaging for a confectionery, including a first preformed part and a second part, wherein the first and second parts are sealed together about the confectionery at flanges that extend away from a main surface of each part, each main surface substantially conforming to the shape of the confectionery and being inherently unstable when placed, in use, on a substantially flat, level surface; a portion of at least one of the flanges being arranged to, in use, contact the substantially flat, level surface when a portion of the main surface of one of the parts also contacts the substantially flat, level surface, wherein such an arrangement allows the confectionery packaging to adopt a stable orientation on the substantially flat, level surface.

Abstract: The present disclosure is directed to anti-VP1 antibodies, antibody fragments, and their uses for the reducing the likelihood or treatment of polyoma virus infection.

Abstract: The invention relates to a resealable package (1, 1?, 1?), comprising a package body (2) having a first side wall (4), a second side wall (6) opposite the first side wall (4), an openable top end (8) and a closed bottom end (10), wherein a portion (12) of the first side wall (4) protrudes beyond the second side wall (6) at the top end (8) in a direction from the bottom end (10) to the top end (8), and a closure element (18) which is releasably adhered to an inner surface (14) of the portion (12) of the first side wall (4) which protrudes beyond the second side wall (6) and the second side wall (6) so as to close the top end (8).

Abstract: The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

Abstract: Disclosed are various embodiments for assigning user interface widgets to page slots associated with a page template. In response to a request to generate a content page, content placement requests are then received from user interface widgets. The page slots are associated with a placement value indicating a value of the page slot relative to other page slots in the page template. The highest ranked user interface widgets according to an effectiveness metric or placement score are scheduled for placement in the content page.

Abstract: A confectionery packaging is provided comprising a first part formed from a preformed shell that is substantially rigid so that the part maintains it shape. The first part holds the product to be packaged, which in the Figures is shown as a confectionery egg. Main surfaces of the first part are shaped so as to substantially conform to the shape of the confectionery egg. Consequently an open mouth to the part is provided. The egg is accessible through the open mouth. A flange is formed about the perimeter of the open mouth. The flange extends away from the main surfaces and continuously about the perimeter of the mouth and extends a substantial distance therefrom in order to provide a surface against which a second part. The confectionery packaging forms a sealed enclosure about the egg by sealing a second part to the flange. To open the packaging, the film is separated from the first part, for instance by peeling back the film.

Abstract: The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.

Abstract: Described is a dynamic web platform configured to provide content rendered with one or more rendering systems. The rendering systems and the modules making up the rendering modules may interact with one another by way of declarative data. Administrators may configure the platform using the declarative data. The declarative data may express operational parameters, business rules, and so forth and may be modified while the platform is operating. The modules in the rendering system may be loosely bound, allowing for concurrent operations, dynamic changes to what content is to be rendered, and so forth.

Abstract: Disclosed are various embodiments for generating a content page with markup language corresponding to user interface widgets. A user interface widget can generate markup language to be incorporated into the content page. The markup language can be analyzed to determine whether it contains a content identifier. The content identifier can be embedded within a portion of a URL. An analysis of the content identifier can be performed to determine whether the content identifier corresponds to expired content.

Abstract: The present disclosure is directed to anti-VP1 antibodies, antibody fragments, and their uses for the reducing the likelihood or treatment of polyoma virus infection.

Abstract: The invention relates to a resealable package (1, 1?, 1?), comprising a package body (2) having a first side wall (4), a second side wall (6) opposite the first side wall (4), an openable top end (8) and a closed bottom end (10), wherein a portion (12) of the first side wall (4) protrudes beyond the second side wall (6) at the top end (8) in a direction from the bottom end (10) to the top end (8), and a closure element (18) which is releasably adhered to an inner surface (14) of the portion (12) of the first side wall (4) which protrudes beyond the second side wall (6) and the second side wall (6) so as to close the top end (8), Upon removal of the closure element (18) from the package body (2), a resealable adhesive arrangement (20, 22; 23; 25) is exposed so as to allow the inner surface (14) of the portion (12) of the first side wall (4) which protrudes beyond the second side wall (6) and an outer surface (16) of the second side wall (6) to be resealably adhered to one another in a position to close the top